Blog
FAQ Category: MPEP 2106.05(E) – Other Meaningful Limitations
-
How does the Classen Immunotherapies Inc. v. Biogen IDEC case exemplify meaningful limitations?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
Schedule a call
Thirty minutes. Chief IP Officer on retainer — and the capital option behind it.
If what you need is something else, we’ll tell you on the same call.